LII Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Lennox International Inc (LII) is not a strong buy for a beginner, long-term investor at this time. The company's recent financial performance shows declining revenue, net income, and EPS, and technical indicators do not suggest a clear upward trend. Analyst sentiment is mixed to negative, with multiple price target reductions and concerns about near-term earnings. While hedge funds are buying, there are no significant insider or congress trading trends, and no recent news or event-driven catalysts to support a strong buy recommendation. Given the investor's preference for long-term growth, it is better to hold off on investing in this stock until there are clearer signs of recovery or growth.
The MACD histogram is negative and expanding, suggesting bearish momentum. RSI is neutral at 45.35, indicating no clear trend. Moving averages are converging, and the stock is trading near its support level of 538.018, with resistance at 570.874. Overall, the technical indicators do not signal a strong buy opportunity.
Hedge funds are significantly increasing their buying activity, with a 2261.11% increase over the last quarter. Gross margin has improved by 2.63% YoY, indicating some operational efficiency.
Revenue, net income, and EPS have all declined significantly in the latest quarter. Analysts have lowered price targets and expressed concerns about near-term earnings and market conditions. Technical indicators do not show a clear upward trend. No recent news or event-driven catalysts to support a strong buy case.
In Q4 2025, revenue dropped by 11.15% YoY to $1.195 billion. Net income decreased by 18.01% YoY to $162.1 million. EPS fell by 16.30% YoY to $4.62. However, gross margin increased by 2.63% YoY to 34.74%. Overall, the financial performance indicates declining growth trends.
Analyst sentiment is mixed to negative. Multiple firms, including Morgan Stanley, Goldman Sachs, and RBC Capital, have lowered price targets, citing weaker sales, margins, and earnings. While some analysts maintain a Buy or Outperform rating, the consensus reflects cautious optimism with concerns about near-term performance.
